Clearing NHS backlog will require pharmacy input despite no mention in plan

The pharmacy sector has a role to play as part of the multidisciplinary team tackling the NHS backlog, pharmacy industry leaders have said.
This comes after the plan for tackling the elective backlog caused by Covid, published by NHS England yesterday (8 February), made no mention of pharmacy’s involvement.
The plan warned that the waiting list for elective care is set to continue growing for the next two years.
According to Mark Lyonette, chief executive of the National Pharmacy Association, the NHS will need ‘all the help it can get in order to deal with waiting lists and the increased burden of disease caused by undiagnosed and undertreated long-term conditions.
Related Article: Pharmacy owners urged to contact LPCs with NHS weight loss service ideas
‘Naturally that includes community pharmacy; our expertise, accessibility and dedication will be needed in the coming years, just as we have been relied upon during the Covid crisis,’ he said.
‘Clearing the NHS backlog requires an end-to-end effort that stretches from self-care and pharmacy support right through to elective surgery in hospitals, plus an enhanced programme of prevention and disease management,’ he explained.
Advice and guidance
The plan, which mentioned the involvement of other areas of primary care and funding which came with that, explained that GPs’ role in tackling the NHS hospital backlog will focus on the use of ‘advice and guidance’ (A&G).
A&G services involve GPs accessing specialist advice by telephone or IT platforms, rather than referring patients for a hospital investigation – with PCNs due to be incentivised for doing so through ‘Investment and Impact Fund’ points worth £9.9m.
Thorrun Govind, English chair of the Royal Pharmaceutical Society (RPS), pointed out that pharmacists have already shown themselves to be key players in the NHS having supported urgent care as well as earlier diagnosis of conditions such as cardiovascular disease.
‘As the third-largest health profession, pharmacists have a clear role to play in the effort to clear the elective backlog, as part of the multidisciplinary team,’ she said.
‘With growing numbers of independent prescribers, there’s a clear opportunity to make the most of pharmacy professional practice to deliver high-quality patient care.’
Related Article: Device to detect counterfeit meds developed by Brighton researchers
However, she said that help from pharmacists will only be possible with a ‘clear workforce plan, backed by appropriate funding, to recruit, retain and train the staff we need’.
Mr Lyonette also called for ‘sufficient funding’ to be made available to the sector so it can play its ‘full part’ in helping the NHS.
Mr Lyonette reiterated previous calls for a Pharmacy First approach to be launched in England, which would ‘empower’ community pharmacists to ‘take pressure off the NHS’.
In October, the health secretary said he is looking into creating a national pharmacy minor ailments service in England, as part of a drive to take pressure off GP practices.
Further details of the delivery plan:
The plan set out targets to:
Related Article: First-line SGLT-2 prescribing proposed for type 2 diabetes in new draft guideline
- Eliminate waits of over one year by March 2025 and waits of over two years by July 2022, acknowledging that some patients will choose to wait longer and there will be ‘challenges’ in particular specialties as before the pandemic;
- Reduce diagnostic waiting times, with the aim of least 95% of patients receiving tests within 6 weeks by March 2025;
- Deliver the ‘cancer faster diagnosis standard’, with at least 75% of urgent cancer referrals receiving a diagnosis within 28 days by March 2024 and return the 62-day backlog to pre-pandemic levels by March 2023.
- Better ‘monitor and improve’ both waiting times and patients’ experience of waiting for first outpatient appointments over the next three years.
It also revealed that:
- A framework to ‘support the review of patients on the waiting list for an outpatient appointment’ is due to be published by March 2022.
- NHS England will ‘work closely with general practice teams’ on support for those who have been waiting a long time for treatment.
- Patients waiting for elective care should be given ‘correct information on decision-making and support offers’ to avoid placing ‘additional strain’ on primary care.
- Patients should be assured it is ‘appropriate and safe’ to be discharged to avoid placing ‘unnecessary demand on general practice from patients attending with outstanding concerns’.
- ‘At least’ 100 community diagnostic centres are planned to be in place over the next three years, with 66 by the end of 2021/22 and an ambition to reach more than 160 across the country.
- The UK Health Security Agency (UKHSA) is ‘continuing to consider ways in which IPC can safely be returned to as close to pre-pandemic conditions as possible’ so that recovery is not slowed by ‘unnecessary stringent measures’.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.